Cancer Genetics — Q2 2015 Earnings Presentation
8 slides from Cancer Genetics's earnings presentation, Aug 11, 2015
Slide 1: Q2 2015 Earnings Call
August 11, 2015 Q2 2015 Earnings Call
Slide 2: Forward-Looking Statements
Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development and potenti
Slide 3: 2nd Quarter 2015 Revenue Highlights
2nd Quarter 2015 Revenue Highlights 3 Cancer Genetics, Inc. | NASDAQ: CGIX | Q2 2015 Earnings Call Q 2 2 0 1 2 Q 2 2 0 1 3 Q 2 2 0 1 4 Q 2 2 0 1 5 0 $4.4 $1.5 $1.8 $1.1 $4.5M $2M 554% BIOPHARMA REVENUE GROWTH FROM Q2 2014 Q2 TOTAL REVENUE GREW FROM $1.5M TO 177% REVENUE GROWTH FROM Q2 2014 $4.2 2014
Slide 4: Revenues By Category
Revenues By Category 4 Cancer Genetics, Inc. | NASDAQ: CGIX | Q2 2015 Earnings Call 64% 30% 6% Q2 2015 BIOPHARMA SERVICES CLINICAL SERVICES DISCOVERY SERVICES $10.2 Mn $4.2 Mn Launched new NGS panels, including Focus::Myeloid™ Entered into preliminary agreement to acquire Response Genetics (OTCQ
Slide 5: Q2 2015 Financial Highlights
Q2 2015 Financial Highlights 5 Q2 2015 revenues were $4.2 million, a 177% increase over Q2 2014 revenues of $1.5 million Revenue from Biopharma Services grew 554% year-over-year during the second quarter while revenue from Clinical Services increased 13% year-over-year during the same period due
Slide 6: Summary Statement of Operations
Summary Statement of Operations 6 Income Statement Item ($ in Thousands) Q2 2013 Q2 2014 Q2 2015 Revenue $1,831 $1,512 $4,185 Gross Profit $ 552 $ 9 $1,087 Gross Margin (%) 30% 1% 26% Research & Development (R&D) $ 455 $1,106 $1,256 Sales & Marketing (S&M) $ 446 $ 919 $1,184 General & Administrative
Slide 7: Proposed Acquisition of Response Genetics
Proposed Acquisition of Response Genetics 7 Cancer Genetics, Inc. | NASDAQ: CGIX | Q2 2015 Earnings Call Response is an oncology-focused central laboratory headquartered in Los Angeles, CA. Founded in 1999 Core business in solid tumor molecular diagnostics Lung cancer, colorectal cancer and me
Slide 8: Thank You
Thank You Cancer Genetics, Inc. www.cancergenetics.com CGI Headquarters Meadows Office Complex 201 Route 17 North, 2nd Floor Rutherford, NJ 07070 Phone: +1 201-528-9200 Fax: +1 201-528-9235 Research Triangle Park 133 Southcenter Court, Ste. 400 Morrisville, NC 27569 Phone: +1 919-465-0100 Fax: +1 91